FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3153984966> ?p ?o ?g. }

• W3153984966 abstract "Tebipenem pivoxil hydrobromide (TBP-PI-HBr) is an orally available prodrug of tebipenem (TBP), a carbapenem with in vitro activity against multidrug-resistant Gram-negative pathogens. This study evaluated the effects of single therapeutic and supratherapeutic doses of TBP-PI-HBr on the heart rate-corrected QT interval (QTc) by assessing the concentration-QT interval relationship using exposure-response modeling. This was a randomized, double-blind, placebo- and active-controlled, single-dose, four-way crossover study. Subjects received single oral doses of TBP-PI-HBr at 600 and 1,200 mg, placebo, and positive control (moxifloxacin at 400 mg). Cardiodynamic electrocardiograms (ECGs) and blood samples were collected in each period. Twenty-four subjects were enrolled. TBP-PI-HBr had no clinically significant adverse effects on heart rate or ECG parameters. The model-predicted slope suggests that the baseline-corrected difference in heart rate from placebo was not importantly affected by plasma TBP concentrations, supporting the use of the QT interval corrected by Fridericia's method as an appropriate correction. The model-predicted difference in QTc at the mean maximum concentration (Cmax) for TBP had negative predicted values for each dose, and no QTc prolongation was detected following TBP-PI-HBr at 600 mg or 1,200 mg. Assay sensitivity was established with moxifloxacin at 400 mg. Exposure to TBP increased in a dose-dependent manner with 600- and 1,200-mg doses. The TBP area under the concentration-time curve from time zero to infinity and Cmax with the 1,200-mg dose were 1.8- and 1.3-fold greater, respectively, than those with the 600-mg dose. TBP-PI-HBr was generally safe and well tolerated, with no effect in QT interval prolongation." @default.
• W3153984966 created "2021-04-26" @default.
• W3153984966 creator A5012172325 @default.
• W3153984966 creator A5031780287 @default.
• W3153984966 creator A5047766808 @default.
• W3153984966 creator A5060861947 @default.
• W3153984966 creator A5069546676 @default.
• W3153984966 creator A5071626944 @default.
• W3153984966 creator A5075951609 @default.
• W3153984966 creator A5087004832 @default.
• W3153984966 date "2021-06-17" @default.
• W3153984966 modified "2023-10-13" @default.
• W3153984966 title "Randomized, Double-Blind, Placebo- and Positive-Controlled Crossover Study of the Effects of Tebipenem Pivoxil Hydrobromide on QT/QTc Intervals in Healthy Subjects" @default.
• W3153984966 cites W1771429770 @default.
• W3153984966 cites W1980463871 @default.
• W3153984966 cites W2084769502 @default.
• W3153984966 cites W2149554320 @default.
• W3153984966 cites W2156718401 @default.
• W3153984966 cites W2297534580 @default.
• W3153984966 cites W2771291368 @default.
• W3153984966 cites W2884832215 @default.
• W3153984966 cites W2911869999 @default.
• W3153984966 cites W2945820657 @default.
• W3153984966 cites W2952967437 @default.
• W3153984966 cites W2955082406 @default.
• W3153984966 cites W3119085584 @default.
• W3153984966 cites W886695988 @default.
• W3153984966 doi "https://doi.org/10.1128/aac.00145-21" @default.
• W3153984966 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/8218669" @default.
• W3153984966 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/33875429" @default.
• W3153984966 hasPublicationYear "2021" @default.
• W3153984966 type Work @default.
• W3153984966 sameAs 3153984966 @default.
• W3153984966 citedByCount "4" @default.
• W3153984966 countsByYear W31539849662022 @default.
• W3153984966 countsByYear W31539849662023 @default.
• W3153984966 crossrefType "journal-article" @default.
• W3153984966 hasAuthorship W3153984966A5012172325 @default.
• W3153984966 hasAuthorship W3153984966A5031780287 @default.
• W3153984966 hasAuthorship W3153984966A5047766808 @default.
• W3153984966 hasAuthorship W3153984966A5060861947 @default.
• W3153984966 hasAuthorship W3153984966A5069546676 @default.
• W3153984966 hasAuthorship W3153984966A5071626944 @default.
• W3153984966 hasAuthorship W3153984966A5075951609 @default.
• W3153984966 hasAuthorship W3153984966A5087004832 @default.
• W3153984966 hasBestOaLocation W31539849661 @default.
• W3153984966 hasConcept C112705442 @default.
• W3153984966 hasConcept C118441451 @default.
• W3153984966 hasConcept C126322002 @default.
• W3153984966 hasConcept C142724271 @default.
• W3153984966 hasConcept C164705383 @default.
• W3153984966 hasConcept C185592680 @default.
• W3153984966 hasConcept C204787440 @default.
• W3153984966 hasConcept C22979827 @default.
• W3153984966 hasConcept C27081682 @default.
• W3153984966 hasConcept C2777008848 @default.
• W3153984966 hasConcept C2777953023 @default.
• W3153984966 hasConcept C2778836808 @default.
• W3153984966 hasConcept C2780367336 @default.
• W3153984966 hasConcept C42219234 @default.
• W3153984966 hasConcept C44249647 @default.
• W3153984966 hasConcept C501593827 @default.
• W3153984966 hasConcept C55493867 @default.
• W3153984966 hasConcept C71924100 @default.
• W3153984966 hasConcept C84393581 @default.
• W3153984966 hasConcept C87813604 @default.
• W3153984966 hasConcept C98274493 @default.
• W3153984966 hasConceptScore W3153984966C112705442 @default.
• W3153984966 hasConceptScore W3153984966C118441451 @default.
• W3153984966 hasConceptScore W3153984966C126322002 @default.
• W3153984966 hasConceptScore W3153984966C142724271 @default.
• W3153984966 hasConceptScore W3153984966C164705383 @default.
• W3153984966 hasConceptScore W3153984966C185592680 @default.
• W3153984966 hasConceptScore W3153984966C204787440 @default.
• W3153984966 hasConceptScore W3153984966C22979827 @default.
• W3153984966 hasConceptScore W3153984966C27081682 @default.
• W3153984966 hasConceptScore W3153984966C2777008848 @default.
• W3153984966 hasConceptScore W3153984966C2777953023 @default.
• W3153984966 hasConceptScore W3153984966C2778836808 @default.
• W3153984966 hasConceptScore W3153984966C2780367336 @default.
• W3153984966 hasConceptScore W3153984966C42219234 @default.
• W3153984966 hasConceptScore W3153984966C44249647 @default.
• W3153984966 hasConceptScore W3153984966C501593827 @default.
• W3153984966 hasConceptScore W3153984966C55493867 @default.
• W3153984966 hasConceptScore W3153984966C71924100 @default.
• W3153984966 hasConceptScore W3153984966C84393581 @default.
• W3153984966 hasConceptScore W3153984966C87813604 @default.
• W3153984966 hasConceptScore W3153984966C98274493 @default.
• W3153984966 hasIssue "7" @default.
• W3153984966 hasLocation W31539849661 @default.
• W3153984966 hasLocation W31539849662 @default.
• W3153984966 hasOpenAccess W3153984966 @default.
• W3153984966 hasPrimaryLocation W31539849661 @default.
• W3153984966 hasRelatedWork W1524573729 @default.
• W3153984966 hasRelatedWork W1966311188 @default.
• W3153984966 hasRelatedWork W2060751623 @default.
• W3153984966 hasRelatedWork W2082471200 @default.
• W3153984966 hasRelatedWork W2332733266 @default.
• W3153984966 hasRelatedWork W3014175262 @default.
• W3153984966 hasRelatedWork W3016386976 @default.

• next